DUBLIN–(BUSINESS WIRE)–The “Global Active Pharmaceutical Ingredients Market 2021-2028” report has been added to ResearchAndMarkets.com’s offering.
Global active pharmaceutical ingredients market will reach $334 billion by 2028, growing by 6.9% annually over 2021-2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2028 with 2021 as the base year.
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global active pharmaceutical ingredients market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Region.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Five Forces
Based on Synthesis, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.
Synthetic API
- Branded Synthetic API
- Generic Synthetic API
Biotech API by Drug Type:
- Monoclonal Antibodies
- Recombinant Proteins
- Vaccines
- Other Biotech APIs
Biotech API by Customer Base:
- Innovative Biologic API
- Generic Biosimilar API
Biotech API by Expression Technology:
- Mammalian Expression
- Microbial Expression
- Yeast Expression
- Insect Expression
- Other Expression Technologies
HPAPI
- Branded HPAPI
- Generic HPAPI
Based on Manufacturing Process, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.
Captive Manufacturing
- Branded Captive API
- Generic Captive API
Merchant Manufacturing by Drug Type:
- Branded Merchant API
- Generic Merchant API
Merchant Manufacturing by Drug Synthesis:
- Merchant Synthetic API
- Merchant Biotech API
By Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.
- Infectious Diseases
- Oncology
- Ophthalmology
- Cardiovascular Disorders
- Central Nervous System
- Pulmonary Disorders
- Orthopedics
- Other Applications
By Drug Type, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.
- Branded Prescription Drugs
- Generic Prescription Drugs
- OTC Drugs
Selected Key Players:
- AbbVie Inc.
- Astrazeneca
- Aurobindo Pharma Ltd.
- BASF
- Bayer AG
- Boehringer Ingelheim
- Catalent Inc.
- Dr. Reddy’s Laboratories
- F. Hoffmann-La Roche
- GlaxoSmithKline plc
- Lonza Group
- Lupin Limited
- Merck & Co., Inc.
- Mylan NV
- Novartis International AG
- Pfizer Inc.
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/v6gc2v
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900